Table 1.
Demographic or characteristic | Training dataset | Validation dataset | p value | ||
---|---|---|---|---|---|
No. of patients | % | No. of patients | % | ||
Sex | 0.947 | ||||
Male | 725 | 56.8 | 425 | 57.0 | |
Female | 551 | 43.2 | 321 | 43.0 | |
Age, years [median (IQR)] | 66 (57–74) | 64 (56–72) | 0.021 | ||
Race | < 0.001 | ||||
White | 1017 | 79.7 | 534 | 71.6 | |
Black | 65 | 5.1 | 86 | 11.5 | |
Others | 194 | 15.2 | 126 | 16.9 | |
Marital status | 0.177 | ||||
Yes | 825 | 64.7 | 460 | 61.7 | |
No | 451 | 35.3 | 286 | 38.3 | |
Grade | 0.407 | ||||
Well-differentiated | 134 | 10.5 | 86 | 11.5 | |
Moderately differentiated | 710 | 55.6 | 386 | 51.7 | |
Poorly differentiated | 423 | 33.2 | 268 | 35.9 | |
Undifferentiated | 9 | 0.7 | 6 | 0.8 | |
Histology | 0.229 | ||||
Adenocarcinoma | 991 | 77.7 | 583 | 78.2 | |
Others | 285 | 22.3 | 143 | 21.8 | |
Regional nodes examined [median (IQR)] | 13 (8–19) | 14 (9–12) | 0.017 | ||
Regional nodes positive [median (IQR)] | 1 (0–2) | 1 (0–3) | 0.003 | ||
LNR [median (IQR)] | 0.05 (0.00–0.20) | 0.07 (0.00–0.22) | 0.010 | ||
Tumor size, mm [median (IQR)] | 21 (15–30) | 22 (15–32) | 0.336 | ||
Extension range | 0.842 | ||||
Localized | 156 | 12.3 | 92 | 12.3 | |
Duodenal wall | 364 | 28.5 | 203 | 27.2 | |
P/C/E | 490 | 38.4 | 284 | 38.1 | |
Adjacent organs or tissues | 266 | 20.8 | 167 | 21.4 | |
AJCC stage | 0.468 | ||||
IA | 123 | 9.6 | 67 | 9.0 | |
IB | 219 | 17.2 | 114 | 15.3 | |
IIA | 169 | 13.2 | 88 | 11.8 | |
IIB | 417 | 32.7 | 268 | 35.9 | |
III | 348 | 27.3 | 209 | 28.0 |
P/C/E pancreas, common bile duct, extrahepatic bile duct, LNR lymph node ratio, AJCC American Joint Committee on Cancer, IQR interquartile range